Metachronous second primary tumours in the aerodigestive tract in patients with early stage head and neck squamous cell carcinomas
- PMID: 15891925
- DOI: 10.1007/s00405-005-0922-5
Metachronous second primary tumours in the aerodigestive tract in patients with early stage head and neck squamous cell carcinomas
Abstract
Early-stage head and neck carcinomas can usually be controlled with the appropriate treatment. In these patients, the long-term prognosis mainly depends on second metachronous malignancies, frequently in the aerodigestive tract. Our study aims to identify risk factors for the appearance of second tumours in this group of patients with early head and neck cancer. Of 949 patients included in the study, 189 (20%) developed a metachronous second primary malignancy, most frequently in the aerodigestive tract. Independent risk factors associated with second tumours were heavy alcohol use and the location of the index tumour in the oropharynx. Compared to non-drinkers, heavy drinkers (>80 g/day) presented a 1.8-times higher risk of a second tumour (CI 95%: 1.01-3.50). Patients with oropharyngeal tumours had a 2.15-higher risk than patients with oral cavity tumours (CI 95%: 1.03-4.47). Recursive partitioning analysis was used to characterise two risk groups for second tumours. The low-risk group included patients over 75 years and patients with low levels of carcinogen use. It comprised 171 patients (18%) with a 5.3% frequency of second tumours. The high-risk group accounted for 80% of the patients (n = 778), and the rate of second neoplasms was 16.3%. Classification of the patients according to the mentioned variables allows us to focus follow-up and prevention efforts on high-risk patients.
Similar articles
-
Survival in second primary malignancies of patients with head and neck cancer.J Laryngol Otol. 2002 Oct;116(10):831-8. doi: 10.1258/00222150260293664. J Laryngol Otol. 2002. PMID: 12437840
-
Synchronous and metachronous head and neck carcinomas.Cancer. 1994 Oct 1;74(7):1933-8. doi: 10.1002/1097-0142(19941001)74:7<1933::aid-cncr2820740718>3.0.co;2-x. Cancer. 1994. PMID: 8082099 Review.
-
Second primary tumours in head and neck cancer.Acta Otorrinolaringol Esp. 2016 May-Jun;67(3):123-9. doi: 10.1016/j.otorri.2015.04.001. Epub 2015 Sep 16. Acta Otorrinolaringol Esp. 2016. PMID: 26386656 English, Spanish.
-
[Malignant multiple neoplasms in head and neck squamous cell carcinoma].Acta Otorrinolaringol Esp. 2008 Nov;59(9):427-32. Acta Otorrinolaringol Esp. 2008. PMID: 19080772 Spanish.
-
The cause of death in patients with head and neck squamous cell carcinoma.J Laryngol Otol. 2002 Apr;116(4):269-71. doi: 10.1258/0022215021910726. J Laryngol Otol. 2002. PMID: 11945186 Review.
Cited by
-
Is there a patient population with squamous cell carcinoma of the head and neck region who might benefit from de-intensification of postoperative radiotherapy? : A monocentric retrospective analysis of a previously defined low-risk patient population treated with standard-of-care radiotherapy.Strahlenther Onkol. 2019 Jun;195(6):482-495. doi: 10.1007/s00066-018-1415-y. Epub 2019 Jan 4. Strahlenther Onkol. 2019. PMID: 30610355 English.
-
Incidence of second primary cancers in oral and pharyngeal cancer patients using a large medical claims database in Japan.J Dent Sci. 2023 Jul;18(3):1047-1054. doi: 10.1016/j.jds.2022.11.025. Epub 2022 Dec 9. J Dent Sci. 2023. PMID: 37404617 Free PMC article.
-
Metachronous second primary malignancy in head and neck cancer patients: is five years of follow-up sufficient?J Korean Assoc Oral Maxillofac Surg. 2018 Oct;44(5):220-224. doi: 10.5125/jkaoms.2018.44.5.220. Epub 2018 Oct 26. J Korean Assoc Oral Maxillofac Surg. 2018. PMID: 30402413 Free PMC article.
-
European Laryngological Society: ELS recommendations for the follow-up of patients treated for laryngeal cancer.Eur Arch Otorhinolaryngol. 2014 Sep;271(9):2469-79. doi: 10.1007/s00405-014-2966-x. Epub 2014 Mar 9. Eur Arch Otorhinolaryngol. 2014. PMID: 24609733 Review.
-
Evaluation of a biomarker based blood test for monitoring surgical resection of oral squamous cell carcinomas.Clin Oral Investig. 2016 Mar;20(2):329-38. doi: 10.1007/s00784-015-1518-0. Epub 2015 Jul 8. Clin Oral Investig. 2016. PMID: 26153867
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical